Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 8Myeloid 5Gastrointestinal 5Head & Neck 4Lymphoid 3CNS 3Thoracic 2Other solid neoplasm 2Dermatologic 2Tumor-Agnostic 1Sarcoma 1Gynecologic 1Genitourinary 1Classical hematology 1Breast 1

Conditions

Neoplasm Metastasis 1Breast Neoplasms 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 215Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Valproic Acid × Breast × Clear all
NCT01900730 2020-02-25

Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 6 charts
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡